Reassignment of HER2 status for subgroups of breast cancer according to the 2018 updated American Society of Clinical Oncology and College of American Pathologists guidelines: The impact of combined immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) reflex testing in a large national reference laboratory.

Katherine B. Geiersbach,Reid G. Meyer,Sara M. Kloft-Nelson,Darlene L. Knutson,Ryan A. Knudson,William R. Sukov,Rhett P. Ketterling,Patricia T. Greipp,Robert B. Jenkins

Reassignment of HER2 status for subgroups of breast cancer according to the 2018 updated American Society of Clinical Oncology and College of American Pathologists guidelines: The impact of combined immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) reflex testing in a large national reference laboratory.

2019

Katherine B. Geiersbach
Reid G. Meyer
Sara M. Kloft-Nelson
Darlene L. Knutson
Ryan A. Knudson
William R. Sukov
Rhett P. Ketterling
Patricia T. Greipp
Robert B. Jenkins

3144Background: Updated ASCO/CAP Guidelines for HER2 testing in breast cancer have been most impactful on the resolution of certain challenging groups of FISH results. We review the change in assig...

Keywords:

Reflex
Clinical Oncology
Oncology
Breast cancer
Fluorescence in situ hybridization
Pathology
Immunohistochemistry
Internal medicine
Medicine
reference laboratory

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations